Finance

Lists
Why is PRE down 2,09%?
Dive Deeper
PRE:NASDAQ
Prenetics Global Ltd
22,00 $
-2,09%
(-0,47) 1D
22,30 $
+1,36% (+0,30)
After hours
Closed: 8 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
22,24 $
High
23,15 $
Low
21,51 $
Mkt. cap
377,16 մլն
Avg. vol.
239,09 հզր
Volume
509,70 հզր
52-wk high
27,24 $
52-wk low
11,36 $
EPS
-2,88 $
Beta
0,40
Shares outstanding
15,56 մլն
No. of employees
98
Open
22,24 $
High
23,15 $
Low
21,51 $
Mkt. cap
377,16 մլն
Avg. vol.
239,09 հզր
Volume
509,70 հզր
52-wk high
27,24 $
52-wk low
11,36 $
EPS
-2,88 $
Beta
0,40
Shares outstanding
15,56 մլն
No. of employees
98
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current 22,00 $
40,00 $ (+81,82%)
Average
37,00 $ (+68,18%)
Lowest
35,00 $ (+59,09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Des Lauriers
Craig-Hallum
Buy
Maintained
-
-
09/22/2026
Unknown Analyst
StoneX
Buy
Reiterated
40,00 $
+81,8%
09/08/2026
Jeff Van Sinderen
B. Riley Securities
Buy
Initiated
37,00 $
+68,2%
08/27/2026
Ryan Meyers
Lake Street
Buy
Reiterated
35,00 $
+59,1%
08/19/2026
George Kelly
Roth MKM
Buy
Maintained
36,00 $
+63,6%
08/19/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
40,00 $
+81,8%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
23,56 մլն
36,56 մլն
35,95 մլն
46,49 մլն
Cost of goods sold
9,53 մլն
14,97 մլն
12,67 մլն
16,28 մլն
Cost of revenue
9,53 մլն
14,97 մլն
12,67 մլն
16,28 մլն
Research and development expenses
1,17 մլն
743,00 հզր
1,44 մլն
757,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,41 մլն
34,13 մլն
31,55 մլն
51,36 մլն
Operating expense
20,19 մլն
35,17 մլն
32,15 մլն
51,18 մլն
Total operating expenses
29,72 մլն
50,14 մլն
44,82 մլն
67,47 մլն
Operating income
-6,16 մլն
-13,58 մլն
-8,87 մլն
-20,98 մլն
Other non operating income
96,00 հզր
9,59 մլն
-17,86 մլն
9,28 մլն
EBT including unusual items
-6,78 մլն
-9,66 մլն
-27,31 մլն
-9,08 մլն
EBT excluding unusual items
-6,78 մլն
-3,87 մլն
-26,74 մլն
-11,71 մլն
Income tax expense
9,00 հզր
38,00 հզր
28,00 հզր
5,00 հզր
Effective tax rate
-0,13%
-0,39%
-0,10%
-0,06%
Other operating expenses
-395,00 հզր
297,00 հզր
-840,00 հզր
-941,00 հզր
Net income
-7,41 մլն
-7,50 մլն
-23,10 մլն
-8,98 մլն
Net profit margin
-31,45%
-20,52%
-64,26%
-19,32%
Earnings per share
-
-0,19
-
-0,52
Interest and investment income
-
1,20 մլն
-
-
Interest expense
-55,00 հզր
-45,00 հզր
-9,00 հզր
-13,00 հզր
Net interest expenses
-55,00 հզր
1,15 մլն
-9,00 հզր
-13,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,33 մլն
-13,34 մլն
-8,71 մլն
-20,80 մլն
Gain or loss from assets sale
-
-
-253,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps